Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028)

Fig. 2

The detection of ctDNA at baseline and the correlation between overall survival and baseline CSF ctDNA positivity. A Positive detection rates of somatic mutations in CSF, plasma, and tissue samples. P-values were calculated using the Fisher’s exact test. B The distribution of max VAF of the three sample types. P-values were calculated using an unpaired two-tailed t-test. C Overall survival of patients with positive and negative CSF ctDNA detection at baseline. P-values were calculated using the log-rank test. Abbreviations: CSF, cerebrospinal fluid; ctDNA, circulating tumor DNA; HR, hazards ratio; VAF, variant allele frequency

Back to article page